Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/United Kingdom/Retatrutide
Purchase and availability checkRetatrutide in the United Kingdom

Can you buy Retatrutide in the United Kingdom?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Retatrutide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
United Kingdom
Source records
3
Reviewed
24 July 2026
ByPeptide Local Editorial DeskUpdated 24 July 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Retatrutide in the United Kingdom?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Retatrutide is an investigational clinical program. No seller listing in the United Kingdom can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Retatrutide in United Kingdom?

Resolve the exact identity of Retatrutide through TRIUMPH-1 Phase 3 study - NCT05929066 from ClinicalTrials.gov. Then search Search licensed medicine product information from Medicines and Healthcare products Regulatory Agency for the destination product record and Search the register from General Pharmaceutical Council for the seller, establishment, or supply route in United Kingdom. A match in one record does not replace the other two checks.

03

Does an online listing prove Retatrutide is authorized or available in United Kingdom?

No. A page using the name Retatrutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For United Kingdom, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Retatrutide clinical trials in United Kingdom

8 study records currently list 87 locations in this country, including 12 locations individually marked Recruiting.

Registry update: 24 July 2026
Study records
8
Listed locations
87
Recruiting locations
12
Records with local recruiting sites
1
NCT07165028
Study-wide statusRecruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Listed locations
17
Recruiting locations
12
Registry update
2026-07-17
NCT06297603
Study-wide statusActive, not recruiting

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Listed locations
9
Recruiting locations
0
Registry update
2026-07-20
NCT06383390
Study-wide statusActive, not recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Listed locations
18
Recruiting locations
0
Registry update
2026-07-20
NCT05929066
Study-wide statusCompleted

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

Listed locations
9
Recruiting locations
0
Registry update
2026-06-03
NCT07232719
Study-wide statusActive, not recruiting

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

Listed locations
12
Recruiting locations
0
Registry update
2026-04-17
NCT06859268
Study-wide statusActive, not recruiting

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

Listed locations
12
Recruiting locations
0
Registry update
2026-03-03
Continue the exact comparison

Related country and compound records.

Compare another tracked name in United Kingdom, or keep Retatrutide fixed and change the destination within Europe. The identity, product, and seller checks remain separate.

Continue the exact comparison

Retatrutide in Europe

Retatrutide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Retatrutide is an investigational clinical program. No seller listing in the United Kingdom can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: TRIUMPH-1 Phase 3 study - NCT05929066 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

TRIUMPH-1 Phase 3 study - NCT05929066

TRIUMPH-1 Phase 3 study - NCT05929066 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open TRIUMPH-1 Phase 3 study - NCT05929066 ↗

Search licensed medicine product information

Search licensed medicine product information is maintained by Medicines and Healthcare products Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Search licensed medicine product information ↗

Search the register

Search the register is maintained by General Pharmaceutical Council. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Search the register ↗
United Kingdom / Country guide

United Kingdom market context.

A website can look clinical without being a registered pharmacy. The GPhC register is the relevant check for Great Britain pharmacy premises and professionals.

  • The GPhC provides a public register for pharmacy professionals and premises in Great Britain.
  • MHRA publishes safety information and enforcement updates for medicines and medical products.
  • A UK price table will launch only after the seller class and delivery claims are verified.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the register

Confirm pharmacy premises and professional details in the official GPhC register.

02

Separate categories

Do not treat a laboratory chemical listing as a substitute for a prescribed medicine.

03

Record the evidence

Keep the seller, batch document, currency, VAT, delivery limit, and date checked together.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT05929066: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightClinicalTrials.gov
02
Search licensed medicine product informationMedicines and Healthcare products Regulatory Agency
03
Search the registerGeneral Pharmaceutical Council
04
What to know about retatrutideEli Lilly and Company
05
Medicines safety guidanceMHRA
06
Retatrutide study search in United KingdomClinicalTrials.gov
07
NCT07165028: A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)ClinicalTrials.gov
08
NCT06297603: Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)ClinicalTrials.gov
09
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)ClinicalTrials.gov
10
NCT07232719: A Study of Retatrutide (LY3437943) in Participants With Obesity or OverweightClinicalTrials.gov
11
NCT06859268: A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With ObesityClinicalTrials.gov
Audit and handoff

Keep the exact record attached.